Condition: Arthritis, Rheumatoid · Colitis, Ulcerative · Sponsor: Eisai Korea Inc.
The purpose of this study is to collect and evaluate the following information in relation to the safety and the efficacy of Jyseleca tablet (Filgotinib Maleate) 100 milligram (mg) and 200 mg in this post marketing setting: (1) Serious adverse events and adverse drug reactions (2) Unexpected adverse events and adverse drug reactions not reflected in precautions for use (3) Known adverse drug reactions (4) Non-serious adverse events and adverse drug reactions (5) Other safety and effectiveness related information will be evaluated in accordance with the permitted articles under the actual conditions of use in Korea.
This description comes directly from the study's public registry record.
Serena SoYoun Kwon · +82-2-3451-5533 · s-kwon@eisaikorea.com
Always discuss trial participation with your own doctor first.
| Soonchunhyang University Cheonan Hospital | Cheonan, Chungcheongnam-do, South Korea | Recruiting |
| Kangwon National University Hospital | Chuncheon, Gangwon-do, South Korea | Recruiting |
| Wonju Severance Christian Hospital | Wŏnju, Gangwon-do, South Korea | Recruiting |
| Korea University Ansan Hospital | Ansan, Gyeonggi-do, South Korea | Recruiting |
| The Catholic University of Korea Bucheon St. Mary's Hospital | Bucheon-si, Gyeonggi-do, South Korea | Recruiting |
| Inje University Ilsan Paik Hospital | Goyang-si, Gyeonggi-do, South Korea | Recruiting |
| Chung-Ang University Gwangmyeong Hospital | Gwangmyeong, Gyeonggi-do, South Korea | Recruiting |
| CHA Bundang Medical Center | Seongnam-si, Gyeonggi-do, South Korea | Recruiting |
| Seoul National University Bundang Hospital | Seongnam-si, Gyeonggi-do, South Korea | Recruiting |
| Ajou University Medical Center | Suwon, Gyeonggi-do, South Korea | Recruiting |
| The Catholic University of Korea St. Vincent's Hospital | Suwon, Gyeonggi-do, South Korea | Recruiting |
| Nowon Eulji Hospital | Uijeongbu-si, Gyeonggi-do, South Korea | Recruiting |
+ 47 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06246123